XML 12 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Statements of Changes In Equity - USD ($)
$ in Thousands
Total
Performance Stock [Member]
Common Stock [Member]
Common Stock [Member]
Performance Stock [Member]
Common Stock [Member]
Director [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Treasury Stock [Member]
Performance Stock [Member]
Treasury Stock [Member]
Director [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Non-Controlling Interests In Subsidiaries [Member]
Balance at Dec. 31, 2022 $ 379,146   $ 272     $ 466,669 $ (1,852)     $ (93,111) $ 6,847 $ 321
Balance (in shares) at Dec. 31, 2022     26,702,161       248,638          
Restricted stock grants 6   $ 6                  
Restricted stock grants (in shares)     525,397                  
Amortization of share awards 4,483         4,483            
Exercise of options 6         6            
Exercise of options (in shares)     834                  
Exercise of warrants     $ 1       $ (1)          
Exercise of warrants (in shares)     117,394       121          
Restricted stock vesting (2,368)           $ (2,368)          
Restricted stock vesting (in shares)     (232,239)       232,239          
Director share awards 1   $ 1                  
Director share awards (in shares)     60,938                  
Forfeiture of employee share awards (in shares)     (15,000)                  
Net Loss (15,043)                 (15,043)    
Other comprehensive income (loss) (594)                   (594)  
Balance at Sep. 30, 2023 365,637   $ 280     471,158 $ (4,221)     (108,154) 6,253 321
Balance (in shares) at Sep. 30, 2023     27,159,485       480,998          
Balance at Jun. 30, 2023 366,855   $ 280     469,618 $ (4,221)     (107,271) 8,128 321
Balance (in shares) at Jun. 30, 2023     27,159,485       480,998          
Amortization of share awards 1,540         1,540            
Net Loss (883)                 (883)    
Other comprehensive income (loss) (1,875)                   (1,875)  
Balance at Sep. 30, 2023 365,637   $ 280     471,158 $ (4,221)     (108,154) 6,253 321
Balance (in shares) at Sep. 30, 2023     27,159,485       480,998          
Balance at Dec. 31, 2023 $ 374,224   $ 280     472,692 $ (4,221)     (102,425) 7,577 321
Balance (in shares) at Dec. 31, 2023 27,665,792   27,184,778       481,014          
Restricted stock grants $ 6   $ 6                  
Restricted stock grants (in shares)     563,271                  
Amortization of share awards 4,829         4,829            
Exercise of options $ 140         140            
Exercise of options (in shares) 12,166   12,166                  
Restricted stock vesting $ (3,120) $ (769)         $ (3,120) $ (769)        
Restricted stock vesting (in shares)     (251,333) 96,150 (3,274)   251,333 61,305 3,274      
Director share awards 1   $ 1                  
Director share awards (in shares)     43,504                  
Net Loss (51,898)                 (51,898)    
Other comprehensive income (loss) 1,595                 (51) 1,646  
Balance at Sep. 30, 2024 $ 325,008   $ 287     477,661 $ (8,110)     (154,374) 9,223 321
Balance (in shares) at Sep. 30, 2024 28,442,188   27,645,262       796,926          
Balance at Jun. 30, 2024 $ 337,938   $ 286     476,020 $ (8,110)     (138,028) 7,449 321
Balance (in shares) at Jun. 30, 2024     27,636,184       796,926          
Amortization of share awards 1,603         1,603            
Exercise of options 38         38            
Exercise of options (in shares)     3,000                  
Director share awards 1   $ 1                  
Director share awards (in shares)     6,078                  
Net Loss (16,346)                 (16,346)    
Other comprehensive income (loss) 1,774                   1,774  
Balance at Sep. 30, 2024 $ 325,008   $ 287     $ 477,661 $ (8,110)     $ (154,374) $ 9,223 $ 321
Balance (in shares) at Sep. 30, 2024 28,442,188   27,645,262       796,926